CPC A61K 38/38 (2013.01) [A23L 33/18 (2016.08); A61K 9/0095 (2013.01); A61K 31/201 (2013.01); A61K 35/20 (2013.01); A61K 47/12 (2013.01); A61P 35/00 (2018.01)] | 11 Claims |
1. A method for preventing formation of a colon cancer, wherein the method comprises administering to an individual that does not have colon cancer, a biologically active complex comprising:
(i) alpha-lactalbumin;
(ii) a variant of alpha-lactalbumin, wherein the variant comprises an alpha-domain and has at least 80% sequence identity to alpha-lactalbumin; or
(iii) a peptide of up to 50 amino acids and comprising an alpha-domain of alpha-lactalbumin; and
(iv) a fatty acid or a salt thereof.
|